Skip to main content

Table 3 Descriptive characteristics for esophageal cancer by ethnicity

From: The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada

  

Iranian

Chinese

South Asian

Other

P

Sex (N = 2873)

Male

10 (71.4%)

94 (74.6%)

57 (47.9%)

1821 (69.7%)

p < 0.001

 

Female

4 (28.6%)

32 (25.4%)

62 (52.1%)

793 (30.3%)

 

Age in years (N = 2873)

Less than 55

0 (0.0%)

14 (11.1%)

21 (17.6%)

314 (12.0%)

0.12

 

55-64

1 (7.1%)

35 (27.8%)

32 (26.9%)

610 (23.3%)

 
 

65-74

9 (64.3%)

41 (32.5%)

35 (29.4%)

858 (32.8%)

 
 

75 and More

4 (28.6%)

36 (28.6%)

31 (26.1%)

832 (31.8%)

 

Years of Diagnosis (N = 2873)

1984-1990

3 (21.4%)

16 (12.7%)

22 (18.5%)

486 (18.6%)

0.164

 

1991-1995

1 (7.1%)

26 (20.6%)

15 (12.6%)

580 (22.2%)

 
 

1996-2000

3 (21.4%)

38 (30.2%)

33 (27.7%)

637 (24.4%)

 
 

2001-2006

7 (50%)

46 (36.5%)

49 (41.2%)

911 (34.9%)

 

Tumor Histology (N = 2873)

SCC *

5 (35.7%)

103 (81.7%)

81 (68.1%)

1389 (53.1%)

p < 0.001

 

AC **

7 (50.0%)

19 (15.1%)

27 (22.7%)

1101 (42.1%)

 
 

Other

2 (14.3%)

4 (3.2%)

11 (9.2%)

124 (4.8%)

 

Tumor Location (N = 2873)

Upper 1/3

2 (14.3%)

23 (18.3%)

17 (14.3%)

314 (12.0%)

p < 0.001

 

Middle 1/3

1 (7.1%)

45 (35.7%)

34 (28.6%)

605 (23.1%)

 
 

Lower 1/3

9 (64.3%)

40 (31.7%)

51 (42.9%)

1383 (52.9%)

 
 

NES/NOS***

2 (14.3%)

18 (14.3%)

17 (14.3%)

312 (12.0%)

 

Tumor Stage (N = 2594)

I

1 (8.3%)

12 (10.3%)

8 (7.6%)

212 (9.0%)

0.84

 

II

6 (50.0%)

66 (56.9%)

56 (53.3%)

1363 (57.8%)

 
 

III

3 (25.0%)

27 (23.3%)

26 (24.8%)

459 (19.4%)

 
 

IV

2 (16.7%)

11 (9.5%)

15 (14.3%)

326 (13.8%)

 

Surgery (N = 2830)

Yes

2 (15.4%)

24 (19.2%)

35 (29.9%)

630 (24.5%)

0.23

 

No

11 (84.6%)

101 (80.8%)

82 (70.1%)

1944 (75.5%)

 

Chemotherapy (N = 2820)

Yes

0 (0.0%)

39 (31.2%)

25 (21.6%)

526 (20.5%)

0.0084

 

No

13 (100.0%)

86 (68.8%)

91 (78.4%)

2039 (79.5%)

 

Radiotherapy (N = 2853)

Yes

13 (100.0%)

112 (89.6%)

111 (93.3%)

2240 (86.3%)

0.052

 

No

0 (0.0%)

13 (10.4%)

8 (6.7%)

355 (13.7%)

 
  1. *SCC squamous cell carcinoma
  2. **AC adenocarcinoma
  3. *** NES not elsewhere specified; NOS not otherwise specified